Definitive Human Studies Showing Indisputable Proof of Clinically Significant Sestamibi Redistribution
The manufacturers and distributors of Sestamibi have long held that two doses of isotope are required for Myocardial Perfusion Imaging (MPI), based upon their representation to physicians, hospitals, clinics, insurance companies including Medicaid and Medicare, the FDA and the Federal Courts, that Sestamibi does NOT redistribute. If these corporations are correct, then the Key words […]